Published in Biochimie on August 01, 1990
Bound water molecules and conformational stabilization help mediate an antigen-antibody association. Proc Natl Acad Sci U S A (1994) 2.18
How do two unrelated antibodies, HyHEL-10 and F9.13.7, recognize the same epitope of hen egg-white lysozyme? Protein Sci (2002) 0.81
Immunochemical pulsed-labeling characterization of intermediates during hen lysozyme oxidative folding. Protein Sci (2002) 0.76
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature (1996) 7.11
Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution. Science (1986) 4.94
On the attribution of binding energy in antigen-antibody complexes McPC 603, D1.3, and HyHEL-5. Biochemistry (1989) 2.56
Crystal structure of the beta chain of a T cell antigen receptor. Science (1995) 2.37
The structural basis of T cell activation by superantigens. Annu Rev Immunol (1999) 2.34
Preliminary refinement and structural analysis of the Fab fragment from human immunoglobulin new at 2.0 A resolution. J Biol Chem (1978) 2.21
Bound water molecules and conformational stabilization help mediate an antigen-antibody association. Proc Natl Acad Sci U S A (1994) 2.18
Three-dimensional structure of antibodies. Annu Rev Immunol (1988) 2.06
Structure and function of the T-cell receptor: insights from X-ray crystallography. Immunol Today (1996) 2.02
Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system. Springer Semin Immunopathol (2000) 1.71
Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature (1999) 1.69
The predicted structure of immunoglobulin D1.3 and its comparison with the crystal structure. Science (1986) 1.68
Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity (1998) 1.68
A common protein fold and similar active site in two distinct families of beta-glycanases. Nat Struct Biol (1995) 1.60
The crystal structure of a llama heavy chain variable domain. Nat Struct Biol (1996) 1.56
Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol (2000) 1.55
Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-A resolution. J Biol Chem (1991) 1.54
Three-dimensional structure of an idiotope-anti-idiotope complex. Nature (1990) 1.47
Domain swapping creates a third putative combining site in bovine odorant binding protein dimer. Nat Struct Biol (1996) 1.46
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity (2001) 1.42
A mutational analysis of binding interactions in an antigen-antibody protein-protein complex. Biochemistry (1998) 1.39
A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. J Exp Med (1998) 1.39
Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis. Biochem J (1999) 1.37
Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels. J Membr Biol (1993) 1.34
Allosteric communication in myosin V: from small conformational changes to large directed movements. PLoS Comput Biol (2008) 1.34
Three-dimensional structure of an antigen-antibody complex at 6 A resolution. Nature (1985) 1.34
Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations. Infect Immun (1981) 1.33
Molecular basis of antigen mimicry by an anti-idiotope. Nature (1995) 1.32
Lysine 271 in the transmembrane domain of the T-cell antigen receptor beta chain is necessary for its assembly with the CD3 complex but not for alpha/beta dimerization. J Biol Chem (1990) 1.29
Three-dimensional structure of a heteroclitic antigen-antibody cross-reaction complex. Proc Natl Acad Sci U S A (1993) 1.22
Mammalian odorant binding proteins. Biochim Biophys Acta (2000) 1.21
Crystal structure of the V alpha domain of a T cell antigen receptor. Science (1995) 1.21
Structural basis of sialyltransferase activity in trypanosomal sialidases. EMBO J (2000) 1.21
Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity. Proc Natl Acad Sci U S A (2000) 1.21
Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplant (2002) 1.20
A mutational analysis of the binding of two different proteins to the same antibody. Biochemistry (1996) 1.18
Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. J Mol Biol (2000) 1.17
Superantigen binding to a T cell receptor beta chain of known three-dimensional structure. J Exp Med (1995) 1.16
Identification of a new component of the agonist binding site of the nicotinic alpha 7 homooligomeric receptor. J Biol Chem (1995) 1.16
Thermodynamics of antigen-antibody binding using specific anti-lysozyme antibodies. Eur J Biochem (1995) 1.14
Estimation of the hydrophobic effect in an antigen-antibody protein-protein interface. Biochemistry (2000) 1.14
The structure of the T cell antigen receptor. Annu Rev Immunol (1996) 1.14
The crystal structure of endoglucanase CelA, a family 8 glycosyl hydrolase from Clostridium thermocellum. Structure (1996) 1.13
High affinity T cell receptors from yeast display libraries block T cell activation by superantigens. J Mol Biol (2001) 1.10
Anatomy of an antibody molecule: structure, kinetics, thermodynamics and mutational studies of the antilysozyme antibody D1.3. Immunol Rev (1998) 1.10
Complexes of porcine odorant binding protein with odorant molecules belonging to different chemical classes. J Mol Biol (2000) 1.09
Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme antibody D44.1. J Mol Biol (1994) 1.09
The structural basis of antigen-antibody recognition. Annu Rev Biophys Biophys Chem (1987) 1.08
Solvent rearrangement in an antigen-antibody interface introduced by site-directed mutagenesis of the antibody combining site. J Mol Biol (1994) 1.08
Differential role of the medial and lateral prefrontal cortices in fear and anxiety. Behav Neurosci (2000) 1.08
Luxury accommodations: the expanding role of structural plasticity in protein-protein interactions. Structure (2000) 1.08
Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human gamma delta T cells. J Immunol (2001) 1.06
Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones. J Med Chem (1991) 1.06
Crystal structure of human CD69: a C-type lectin-like activation marker of hematopoietic cells. Biochemistry (2000) 1.06
Role of the T cell receptor ligand affinity in T cell activation by bacterial superantigens. J Biol Chem (2001) 1.05
Role of the T cell receptor alpha chain in stabilizing TCR-superantigen-MHC class II complexes. Immunity (1999) 1.04
Analysis of binding interactions in an idiotope-antiidiotope protein-protein complex by double mutant cycles. Biochemistry (1997) 1.04
Structure of the Vdelta domain of a human gammadelta T-cell antigen receptor. Nature (1998) 1.04
Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,). Biochemistry (2000) 1.03
MHC class I molecules, structure and function. Rev Immunogenet (1999) 1.03
Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. Pediatr Infect Dis J (1996) 1.02
Interaction of blood platelets with a microfibrillar extract from adult bovine aorta: requirement for von Willebrand factor. Proc Natl Acad Sci U S A (1983) 1.02
Determinants involved in regulating the proportion of edited apolipoprotein B RNAs. RNA (1996) 1.01
Murine immunoprotective activity of Klebsiella pneumoniae cell surface preparations: comparative study with ribosomal preparations. Infect Immun (1981) 1.01
Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120. J Mol Biol (1998) 1.01
The crystal structure of a family 5 endoglucanase mutant in complexed and uncomplexed forms reveals an induced fit activation mechanism. J Mol Biol (1996) 1.00
Crystal structure of a cross-reaction complex between Fab F9.13.7 and guinea fowl lysozyme. J Biol Chem (1995) 0.99
Structural and functional analysis of the metal-binding sites of Clostridium thermocellum endoglucanase CelD. J Biol Chem (1995) 0.98
The insect attractant 1-octen-3-ol is the natural ligand of bovine odorant-binding protein. J Biol Chem (2000) 0.97
A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system. Mol Pharmacol (1999) 0.96
A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts. Br J Cancer (1999) 0.96
Preliminary crystallographic study of the complex between the Fab fragment of a monoclonal anti-lysozyme antibody and its antigen. J Mol Biol (1983) 0.96
The effect of water activity on the association constant and the enthalpy of reaction between lysozyme and the specific antibodies D1.3 and D44.1. J Mol Recognit (1996) 0.95
Imperfect interfaces. Nat Struct Biol (1998) 0.94
Effects of UV and visible radiation on DNA-final base damage. Biol Chem (1997) 0.94
The structure of an entire noncovalent immunoglobulin kappa light-chain dimer (Bence-Jones protein) reveals a weak and unusual constant domains association. Eur J Biochem (1999) 0.93
Crystal structure of a ternary complex between human chorionic gonadotropin (hCG) and two Fv fragments specific for the alpha and beta-subunits. J Mol Biol (1999) 0.92
Three-dimensional structure and thermodynamics of antigen binding by anti-lysozyme antibodies. Biochem Soc Trans (1993) 0.92
Ethanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the amino-terminal domain of the receptor. Mol Pharmacol (1996) 0.92
Superantigen recognition by gammadelta T cells: SEA recognition site for human Vgamma2 T cell receptors. Immunity (2001) 0.92
The management of severe vaginal obstruction from genital chronic graft-versus-host disease: diagnosis, surgical technique and follow-up. Minerva Ginecol (2006) 0.92
Monoclonal Ig L chain and L chain V domain fragment crystallization in myeloma-associated Fanconi's syndrome. J Immunol (1993) 0.91
Crystallization and preliminary X-ray diffraction study of the bacterially expressed Fv from the monoclonal anti-lysozyme antibody D1.3 and of its complex with the antigen, lysozyme. J Mol Biol (1990) 0.90
Monoclonal antibody recognizing pre-S(2) epitope of hepatitis B virus: characterization of pre-S(2) epitope and anti-pre-S(2) antibody. J Med Virol (1986) 0.90
C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG. Immunology (1976) 0.90
Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives. Mol Pharmacol (1995) 0.90
The New York High-Risk Project: social and general intelligence in children at risk for schizophrenia. Schizophr Res (1998) 0.90
Characterization of monoclonal antibodies specific for the pre-S2 region of the hepatitis B virus envelope protein. Mol Immunol (1986) 0.90
Selection, characterization and x-ray structure of anti-ampicillin single-chain Fv fragments from phage-displayed murine antibody libraries. J Mol Biol (2001) 0.90
Structural changes induced in proteins by therapeutic ultrasounds. Ultrasonics (2009) 0.90
Determination of detergent critical micellar concentration by solubilization of a colored dye. Anal Biochem (1993) 0.89